What do the guidelines suggest for non-Vitamin K antagonist oral anticoagulant use for stroke prevention in atrial fibrillation?

Farhan Shahid; Eduard Shantsila; Gregory Y.H. Lip

doi:10.1093/eurheartj/suw049

What do the guidelines suggest for non-Vitamin K antagonist oral anticoagulant use for stroke prevention in atrial fibrillation?

Farhan Shahid, Eduard Shantsila, Gregory Y.H. Lip^*

^*Kontaktforfatter

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

2 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	European Heart Journal, Supplement
Vol/bind	18
Udgave nummer	suppl. 1
Sider (fra-til)	I18-I24
ISSN	1554-2815
DOI	https://doi.org/10.1093/eurheartj/suw049
Status	Udgivet - 2016

Adgang til dokumentet

10.1093/eurheartj/suw049

Andre filer og links

http://www.scopus.com/inward/record.url?scp=85015880145&partnerID=8YFLogxK

Fingeraftryk Dyk ned i forskningsemnerne om 'What do the guidelines suggest for non-Vitamin K antagonist oral anticoagulant use for stroke prevention in atrial fibrillation?'. Sammen danner de et unikt fingeraftryk.

Citationsformater

@article{154f78a4d3064ef79d9e93fe4a497ace,

title = "What do the guidelines suggest for non-Vitamin K antagonist oral anticoagulant use for stroke prevention in atrial fibrillation?",

keywords = "Atrial fibrillation, Bleeding, Kidney disease, Non-Vitamin K oral anticoagulants, Reversal agents, Stroke, Warfarin",

author = "Farhan Shahid and Eduard Shantsila and Lip, {Gregory Y.H.}",

year = "2016",

doi = "10.1093/eurheartj/suw049",

language = "English",

volume = "18",

pages = "I18--I24",

journal = "European Heart Journal Supplements",

issn = "1554-2815",